HLA-B Antikörper (FITC)
-
- Target Alle HLA-B Antikörper anzeigen
- HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-B Antikörper ist konjugiert mit FITC
-
Applikation
- Flow Cytometry (FACS)
- Spezifität
- Recognizes human HLA Class 1 Antigen B8. Cross-reacts with B59.
- Aufreinigung
- Ion exchange chromatography
- Immunogen
- HLA Class 1 Antigen B8.
- Isotyp
- IgG2b
- Top Product
- Discover our top product HLA-B Primärantikörper
-
-
- Applikationshinweise
-
Approved: Flo
Usage: Suitable for use in Flow Cytometry, Cell Typing, Tissue Staining and Chimerism Studies. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, 0.05 % sodium azide, 0.5 % BSA.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- avoid freeze thaw cycles. Store undiluted.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles. Store undiluted.
-
- Target
- HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))
- Andere Bezeichnung
- HLA-B (HLA-B Produkte)
- Synonyme
- AS antikoerper, HLAB antikoerper, SPDA1 antikoerper, mhc1b antikoerper, major histocompatibility complex, class I, B antikoerper, major histocompatibility complex nonclassical class Ib L homeolog antikoerper, HLA-B antikoerper, BOLA-B antikoerper, MAMU-B18 antikoerper, DKFZP469N1225 antikoerper, mhc1b.L antikoerper
- Hintergrund
-
Name/Gene ID: HLA-B
Synonyms: HLA-B, HLAB, MHC Class I HLA heavy chain, Leukocyte antigen class I-B, SPDA1 - Gen-ID
- 3106
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-